Method of treating dry eye disorders using 13(S)-HODE and its analogs
申请人:Klimko G. Peter
公开号:US20060128803A1
公开(公告)日:2006-06-15
The topical use of 13(S)-HODE and analogs are disclosed for the treatment of dry eye disorders.
本发明揭示了用于治疗干眼症的13(S)-HODE和类似物的局部应用。
Novel prostaglandin analogues and process for making same
申请人:THE PROCTER & GAMBLE COMPANY
公开号:EP0061209B1
公开(公告)日:1985-09-04
NOVEL PROCESS
申请人:AstraZeneca Aktiebolag
公开号:EP1075464A1
公开(公告)日:2001-02-14
[EN] NOVEL PROCESS<br/>[FR] NOUVEAU PROCEDE
申请人:ASTRAZENECA AB
公开号:WO1999044990A1
公开(公告)日:1999-09-10
(EN) The invention relates to novel process for the preparation of prostaglandin compounds which are useful as medicaments.(FR) L'invention concerne un nouveau procédé de préparation de composés de prostaglandine s'utilisant comme médicaments.
[EN] METHOD OF TREATING DRY EYE DISORDERS USING 13(S)-HODE AND ITS ANALOGS<br/>[FR] PROCEDE DE TRAITEMENT DES TROUBLES ASSOCIES A LA KERATOCONJONCTIVITE SECHE PAR LE 13(S)-HODE ET SES ANALOGUES
申请人:ALCON INC
公开号:WO2006065916A1
公开(公告)日:2006-06-22
[EN] The topical use of 13(S)-HODE and analogs are disclosed for the treatment of dry eye disorders. [FR] L'invention porte sur l'utilisation topique de 13(S)-HODE et de ses analogues dans le traitement des troubles associés à la kératoconjonctivite sèche.